| Financial Year |
March 31 2023 |
| Monetary Funds |
3,110,648,591.66 |
| Held-for-trading Financial Assets |
125,896,390.85 |
| Notes Receivable |
4,733,270.00 |
| Accounts Receivable |
1,953,114,607.46 |
| Advances to Suppliers |
1,900,470,134.93 |
| Other Receivables |
145,285,249.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
1,972,102.83 |
| Dividend Receivable |
-- |
| Inventories |
3,911,512,772.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
210,251,976.09 |
| Total Current Assets |
11,361,912,992.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
75,501,355.22 |
| Investment Properties |
-- |
| Fixed Assetes |
38,544,112.33 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,761,739.91 |
| R&D expenses |
76,489.70 |
| Goodwill |
53,032,753.28 |
| Long-Term Deferred and Prepaid Expenses |
20,597,510.54 |
| Deferred Income Tax Assets |
146,481,963.15 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,088,838,274.72 |
| Total Assets |
13,450,751,267.05 |
| Short-Term Loans |
3,976,869,552.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
45,491,526.90 |
| Accounts Payable |
671,263,496.12 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
63,126,118.28 |
| Taxes Payable |
271,595,789.82 |
| Interest Payable |
5,077,835.57 |
| Dividend Payable |
-- |
| Other payables |
210,396,156.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
281,912,957.08 |
| Other Current Liabilities |
158,712,876.51 |
| Sub-Total of Current Liabilities |
6,900,236,754.80 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
3,563,507.74 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
13,251,734.83 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
51,759,028.29 |
| Total Liabilities |
6,951,995,783.09 |
| Paid-In Capital(Or Share Stock) |
1,239,281,806.00 |
| Capital Surplus |
1,626,251,519.91 |
| Surplus Reserve |
424,837,826.33 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,818,831,888.85 |
| Minority Stockholder's Interest |
393,745,610.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,105,009,873.19 |
| Owner's Equity（Stockholder's Equity） |
6,498,755,483.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,450,751,267.05 |
